ChiVax-gD

N/A

Report date: 2025/01/26 18:21:31

Base Information

Drug NameChiVax-gD

Drug Alias NameBTLA checkpoint inhibitor vaccine (Virion Therapeutics)gD-expressing adenoviral vector vaccine (Virion Therapeutics)glycoprotein D-expressing adenoviral vector vaccine (Virion Therapeutics)BTLA checkpoint inhibitor (Virion Therapeutics)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionB- and T-lymphocyte attenuator blockers

TargetsB- and T-lymphocyte attenuator

Therapy Area/IndicationsNeoplasmsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVirion Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesVirion Therapeutics LLC

Inactive CompaniesN/A

Active IndicationsNeoplasmsVirus Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A